GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU)

Clinical trial NCT03890432 · COMPLETED

Trial details

NCT number: NCT03890432
Sponsor: HEIDEGGER CP
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Critical Illness Energy Supply; Deficiency, Severe Protein Deficiency Hypoglycemia Hyperglycemia

Start date: 2023-01-10
Primary completion: 2025-01-26
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.